Authors:
Hombach, A
Heuser, C
Gerken, M
Fischer, B
Lewalter, K
Diehl, V
Pohl, C
Abken, H
Citation: A. Hombach et al., T cell activation by recombinant Fc epsilon RI gamma-chain immune receptors: an extracellular spacer domain impairs antigen-dependent T cell activation but not antigen recognition, GENE THER, 7(12), 2000, pp. 1067-1075
Authors:
Wilde, S
Jetter, A
Menzel, H
Rietbrock, S
Zaigler, M
Sieber, M
Tesch, H
Hempel, G
Reif, S
Jaehde, U
Merkel, U
Johnson, S
Diehl, V
Fuhr, U
Citation: S. Wilde et al., Population pharmacokinetics of drugs in the BEACOPP chemotherapy regimen used in Hodgkin's disease, INT J CL PH, 38(3), 2000, pp. 147-149
Authors:
Chemnitz, J
Fuchs, M
Blau, W
Hartmann, P
Wickenhauser, C
Scheid, C
Schulz, A
Diehl, V
Sohngen, D
Citation: J. Chemnitz et al., Fatal thrombotic thrombocytopenic purpura as a rare complication followingallogeneic stem cell transplantation, ANN HEMATOL, 79(9), 2000, pp. 527-529
Authors:
Bohlen, H
Kessler, M
Sextro, M
Diehl, V
Tesch, H
Citation: H. Bohlen et al., Poor clinical outcome of patients with Hodgkin's Disease and elevated interleukin-10 serum levels - Clinical significance of interleukin-l0 serum levels for Hodgkin's disease, ANN HEMATOL, 79(3), 2000, pp. 110-113
Authors:
Schafer, H
Hubel, K
Bohlen, H
Mansmann, G
Hegener, K
Richarz, B
Oberhauser, F
Wassmer, G
Holscher, AH
Pichlmaier, H
Diehl, V
Engert, A
Citation: H. Schafer et al., Perioperative treatment with Filgrastim stimulates granulocyte function and reduces infectious complications after esophagectomy, ANN HEMATOL, 79(3), 2000, pp. 143-151
Authors:
Muller, A
Bialek, R
Fatkenheuer, G
Salzberger, B
Diehl, V
Franzen, C
Citation: A. Muller et al., Detection of Isospora belli by polymerase chain reaction using primers based on small-subunit ribosomal RNA sequences, EUR J CL M, 19(8), 2000, pp. 631-634
Authors:
Franzen, C
Muller, A
Bialek, R
Diehl, V
Salzberger, B
Fatkenheuer, G
Citation: C. Franzen et al., Taxonomic position of the human intestinal protozoan parasite Isospora belli based on ribosomal RNA sequences, PARASIT RES, 86(8), 2000, pp. 669-676
Authors:
Engel, C
Loeffler, M
Schmitz, S
Tesch, H
Diehl, V
Citation: C. Engel et al., Acute hematologic toxicity and practicability of dose-intensified BEACOPP chemotherapy for advanced stage Hodgkin's disease, ANN ONCOL, 11(9), 2000, pp. 1105-1114
Citation: M. Sieber et al., Treatment of Hodgkin's disease: Current strategies of the German Hodgkin'sLymphoma Study Group (vol 10, pg S23, 1999), ANN ONCOL, 11(6), 2000, pp. 765-765
Authors:
Franklin, J
Paulus, U
Lieberz, D
Breuer, K
Tesch, H
Diehl, V
Citation: J. Franklin et al., Is the international prognostic score for advanced stage Hodgkin's diseaseapplicable to early stage patients?, ANN ONCOL, 11(5), 2000, pp. 617-623
Citation: M. Sieber et al., Treatment of Hodgkin's disease: Results and current concepts of the GermanHodgkin's Lymphoma Study Group, ANN ONCOL, 11, 2000, pp. 81-85
Authors:
Pfitzner, T
Engert, A
Wittor, H
Schinkothe, T
Oberhauser, F
Schulz, H
Diehl, V
Barth, S
Citation: T. Pfitzner et al., A real-time PCR assay for the quantification of residual malignant cells in B cell chronic lymphatic leukemia, LEUKEMIA, 14(4), 2000, pp. 754-766
Authors:
Schnell, R
Vitetta, E
Schindler, J
Borchmann, P
Barth, S
Ghetie, V
Hell, K
Drillich, S
Diehl, V
Engert, A
Citation: R. Schnell et al., Treatment of refractory Hodgkin's lymphoma patients with an anti-CD25 ricin A-chain immunotoxin, LEUKEMIA, 14(1), 2000, pp. 129-135
Authors:
Rueffer, U
Josting, A
Franklin, J
May, M
Sieber, M
Breuer, K
Engert, A
Diehl, V
Citation: U. Rueffer et al., Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: Incidence, treatment, and prognosis, J CL ONCOL, 19(7), 2000, pp. 2026-2032
Authors:
Josting, A
Reiser, M
Rueffer, U
Salzberger, B
Diehl, V
Engert, A
Citation: A. Josting et al., Treatment of primary progressive Hodgkin's and aggressive non-Hodgkin's lymphoma: Is there a chance for cure?, J CL ONCOL, 18(2), 2000, pp. 332-339
Authors:
Santoro, A
Bredenfeld, H
Devizzi, L
Tesch, H
Bonfante, V
Viviani, S
Fielder, F
Parra, HS
Benoehr, C
Pacini, M
Bonadonna, G
Diehl, V
Citation: A. Santoro et al., Gemcitabine in the treatment of refractory Hodgkins's disease: Results of a multicenter phase II study, J CL ONCOL, 18(13), 2000, pp. 2615-2619
Authors:
Thiele, J
Kvasnicka, HM
Zankovich, R
Diehl, V
Citation: J. Thiele et al., Relevance of bone marrow features in the differential diagnosis between essential thrombocythemia and early stage idiopathic myelofibrosis, HAEMATOLOG, 85(11), 2000, pp. 1126-1134